Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue	Net income ▾	Net margin	Return on equity	Revenue growth	Diluted EPS
PHAT	Phathom Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$175.11M	-$221.25M	-126.3%	n/a	216.9%	-$3.03
RCKT	Rocket Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$223.12M	n/a	-80.5%	n/a	-$2.01
OPK	Opko Health, Inc. Manufacturing · Year ended 2025-12-31 · USD	$606.88M	-$225.68M	-37.2%	-17.8%	-14.9%	-$0.30
MLTX	MoonLake Immunotherapeutics Manufacturing · Year ended 2025-12-31 · USD	n/a	-$227.32M	n/a	-74.7%	n/a	-$3.53
ELAN	Elanco Animal Health Inc Manufacturing · Year ended 2025-12-31 · USD	$4.71B	-$232.00M	-4.9%	-3.5%	6.2%	-$0.47
ALMS	Alumis Inc. Manufacturing · Year ended 2025-12-31 · USD	$24.05M	-$243.32M	n/m	-80.8%	n/a	-$2.86
PRTA	Prothena Corp Public Ltd Co Manufacturing · Year ended 2025-12-31 · USD	$9.68M	-$244.09M	n/m	-87.0%	-92.8%	-$4.53
PGEN	Precigen, Inc. Manufacturing · Year ended 2025-12-31 · USD	$9.68M	-$250.64M	n/m	n/m	146.7%	-$1.37
NRIX	Nurix Therapeutics, Inc. Manufacturing · Year ended 2025-11-30 · USD	$83.98M	-$264.46M	-314.9%	-49.1%	54.0%	-$3.05
OCUL	Ocular Therapeutix, Inc Manufacturing · Year ended 2025-12-31 · USD	$51.95M	-$265.94M	-511.9%	-40.6%	-18.5%	-$1.42
LYEL	Lyell Immunopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$36.0K	-$274.45M	n/m	-110.6%	-41.0%	-$16.06
KURA	Kura Oncology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$67.48M	-$278.67M	-412.9%	-160.0%	25.2%	-$3.18
SNDX	Syndax Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$172.35M	-$285.42M	-165.6%	-441.6%	627.8%	-$3.29
CMPS	COMPASS Pathways plc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$287.86M	n/a	n/a	n/a	-$3.08
MDGL	Madrigal Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$958.40M	-$288.28M	-30.1%	-47.8%	432.1%	-$12.85
NERV	Minerva Neurosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$293.42M	n/a	n/a	n/a	-$34.67
VERA	Vera Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$299.62M	n/a	-49.6%	n/a	-$4.66
ROIV	Roivant Sciences Ltd. Manufacturing · Year ended 2026-03-31 · USD	$8.26M	-$299.77M	n/m	-6.6%	-71.6%	-$0.54
PRAX	Praxis Precision Medicines, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$303.27M	n/a	-34.5%	-100.0%	-$13.48
COGT	Cogent Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$328.94M	n/a	-51.7%	n/a	-$2.16
VRDN	Viridian Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$70.85M	-$342.60M	-483.6%	-47.4%	n/m	n/a
XENE	Xenon Pharmaceuticals Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.50M	-$345.91M	n/m	-59.5%	n/a	-$4.36
RCUS	Arcus Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$247.00M	-$353.00M	-142.9%	-55.9%	-4.3%	-$3.29
JAZZ	Jazz Pharmaceuticals plc Manufacturing · Year ended 2025-12-31 · USD	$4.27B	-$356.15M	-8.3%	-8.2%	4.9%	-$5.84
VKTX	Viking Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$359.64M	n/a	-56.3%	n/a	-$3.19

Rows per page: 2550 100